» Articles » PMID: 32291811

Availability, Retail Price and Potency of Legal and Illegal Cannabis in Canada After Recreational Cannabis Legalisation

Overview
Specialty Psychiatry
Date 2020 Apr 16
PMID 32291811
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction And Aims: There is little objective market data on the price or potency of legal and illegal cannabis products following recreational cannabis legalisation.

Design And Methods: In the 2 months post-legalisation in Canada (November-December 2018), legal and illegal cannabis retailers were identified from government lists and online directories. The store location, price and Δ9-tetrahydrocannabinol (THC) and cannabidiol levels of dried herb and cannabis cookies were collected from retailer websites or Weedmaps.

Results: We identified 185 legal retailers (22 online stores, 163 storefronts; 65 government-run stores, 120 private stores) and 944 illegal retailers (791 delivery-only services, 157 storefronts). Relative to legal dried herb, illegal dried herb was lower in price (1 g: $10.23 vs. $11.08, ⅛ oz: $9.37/g vs. $10.88/g, ½ oz: $8.18/g vs. $8.85/g; P < 0.05 for all) and higher in potency (THC: 20.5% vs. 16.1%, cannabidiol: 2.4% vs. 1.7%; P < 0.05 for both). Legal private stores had higher prices for dried herb than government-run stores (1 g: $13.08 vs. $10.89, ⅛ oz: $12.75/g vs. $10.45/g, ½ oz: $10.85/g vs. $8.71/g, 1 oz: $8.54/g vs. $7.22/g; P < 0.05 for all). On average, one cannabis cookie in the illegal market contained 96 mg of THC and cost $1.57 per 10 mg of THC.

Discussion And Conclusions: In the 2 months post-legalisation, illegal cannabis was less expensive, with higher labelled THC content than legal cannabis, although the scope of these differences was more modest than estimates from other crowdsourced and self-reported data. Direct monitoring of cannabis price and potency from legal and illegal retailers is needed to examine the impact of legalisation over time.

Citing Articles

Unveiling the Complexities of Medications, Substance Abuse, and Plants for Recreational and Narcotic Purposes: An In-Depth Analysis.

Predescu I, Jijie A, Patrascu D, Pasc A, Piros E, Trandafirescu C Pharmacy (Basel). 2025; 13(1).

PMID: 39998006 PMC: 11859396. DOI: 10.3390/pharmacy13010007.


Cannabis use characteristics and associations with problematic use outcomes, quitting-related factors, and mental health among US young adults.

Berg C, LoParco C, Romm K, Cui Y, McCready D, Wang Y Subst Abuse Treat Prev Policy. 2025; 20(1):1.

PMID: 39799369 PMC: 11725203. DOI: 10.1186/s13011-025-00634-0.


Changes in Cannabis Use Patterns in Psychiatric Populations Pre- and Post-Legalization of Recreational Cannabis Use in Canada: A Repeated Cross-Sectional Survey.

Sorkhou M, Johnstone S, Weinberger A, Cooper Z, Sanches M, Castle D Cannabis. 2025; 7(3):1-13.

PMID: 39781550 PMC: 11705070. DOI: 10.26828/cannabis/2024/000238.


Recreational cannabis excise taxation in the USA: Constructing a comparable tax measure for empirical analysis.

Park H, Yoon D, Yang Q, He Y, Han B, Shi Y Int J Drug Policy. 2024; 134():104630.

PMID: 39522235 PMC: 11706241. DOI: 10.1016/j.drugpo.2024.104630.


Cannabis-Derived Product Types, Flavors, and Compound Types From an E-Commerce Website.

Nali M, Yang J, Li Z, Larsen M, Mackey T JAMA Netw Open. 2024; 7(10):e2440376.

PMID: 39432307 PMC: 11581530. DOI: 10.1001/jamanetworkopen.2024.40376.